BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20155842)

  • 1. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.
    Ng SC; Plamondon S; Kamm MA; Hart AL; Al-Hassi HO; Guenther T; Stagg AJ; Knight SC
    Inflamm Bowel Dis; 2010 Aug; 16(8):1286-98. PubMed ID: 20155842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis.
    Ng SC; Plamondon S; Al-Hassi HO; English N; Gellatly N; Kamm MA; Knight SC; Stagg AJ
    Clin Exp Immunol; 2009 Nov; 158(2):205-18. PubMed ID: 19737136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease.
    Ng SC; Benjamin JL; McCarthy NE; Hedin CR; Koutsoumpas A; Plamondon S; Price CL; Hart AL; Kamm MA; Forbes A; Knight SC; Lindsay JO; Whelan K; Stagg AJ
    Inflamm Bowel Dis; 2011 Oct; 17(10):2027-37. PubMed ID: 21910165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of intestinal dendritic cells in inflammatory bowel diseases.
    Hart AL; Al-Hassi HO; Rigby RJ; Bell SJ; Emmanuel AV; Knight SC; Kamm MA; Stagg AJ
    Gastroenterology; 2005 Jul; 129(1):50-65. PubMed ID: 16012934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.
    Al-Hassi HO; Mann ER; Sanchez B; English NR; Peake ST; Landy J; Man R; Urdaci M; Hart AL; Fernandez-Salazar L; Lee GH; Garrote JA; Arranz E; Margolles A; Stagg AJ; Knight SC; Bernardo D
    Mol Nutr Food Res; 2014 May; 58(5):1132-43. PubMed ID: 24347371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease.
    Ghavami SB; Yadegar A; Aghdaei HA; Sorrentino D; Farmani M; Mir AS; Azimirad M; Balaii H; Shahrokh S; Zali MR
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human dendritic cell phenotype and function by probiotic bacteria.
    Hart AL; Lammers K; Brigidi P; Vitali B; Rizzello F; Gionchetti P; Campieri M; Kamm MA; Knight SC; Stagg AJ
    Gut; 2004 Nov; 53(11):1602-9. PubMed ID: 15479680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of moxibustion with different duration on colonic epithelial structure, serum inflammatory cytokines, and intestinal mucosa inflammatory cell signal transduction pathways].
    Ma TM; Han Y; Ma XD; Zeng XX; Ge W
    Zhen Ci Yan Jiu; 2014 Feb; 39(1):20-6. PubMed ID: 24684107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Matsuno H; Kayama H; Nishimura J; Sekido Y; Osawa H; Barman S; Ogino T; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Uchino M; Ikeuchi H; Doki Y; Mori M; Takeda K; Mizushima T
    Inflamm Bowel Dis; 2017 Sep; 23(9):1524-1534. PubMed ID: 28700533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
    Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
    Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.
    Mann ER; Bernardo D; Ng SC; Rigby RJ; Al-Hassi HO; Landy J; Peake ST; Spranger H; English NR; Thomas LV; Stagg AJ; Knight SC; Hart AL
    Inflamm Bowel Dis; 2014 Dec; 20(12):2299-307. PubMed ID: 25397892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis.
    D'Incà R; Barollo M; Scarpa M; Grillo AR; Brun P; Vettorato MG; Castagliuolo I; Sturniolo GC
    Dig Dis Sci; 2011 Apr; 56(4):1178-87. PubMed ID: 20737210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
    Tursi A; Brandimarte G; Papa A; Giglio A; Elisei W; Giorgetti GM; Forti G; Morini S; Hassan C; Pistoia MA; Modeo ME; Rodino' S; D'Amico T; Sebkova L; Sacca' N; Di Giulio E; Luzza F; Imeneo M; Larussa T; Di Rosa S; Annese V; Danese S; Gasbarrini A
    Am J Gastroenterol; 2010 Oct; 105(10):2218-27. PubMed ID: 20517305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The probiotic mixture VSL#3 mediates both pro- and anti-inflammatory responses in bone marrow-derived dendritic cells from C57BL/6 and BALB/c mice.
    Mariman R; Kremer B; Koning F; Nagelkerken L
    Br J Nutr; 2014 Oct; 112(7):1088-97. PubMed ID: 25181025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions.
    Kapoor K; Eissa N; Tshikudi D; Bernstein CN; Ghia JE
    World J Gastroenterol; 2021 Dec; 27(47):8138-8155. PubMed ID: 35068859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation.
    Xu Q; Katz J; Zhang P; Ashtekar AR; Gaddis DE; Fan M; Michalek SM
    Infect Immun; 2011 Sep; 79(9):3792-800. PubMed ID: 21746857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.